Another study conducted by Cui et al. revealed that miR-126 could potentially induce TMZ sensitivity and overcome resistance in GBM cells, by downregulating the expression of SOX2 (oncoprotein and associated with drug resistance in cancer) and Wnt/β catenin signaling. Here, SOX2 is linked to glioblastoma.